Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1829740 | 0.87 | TDP1 (0.41) | TDP1LMNAKDM4ETSHR | |
| SCHEMBL12517107 | 0.85 | TDP1 (0.40) | TDP1KDM4ETSHR | |
| SCHEMBL2353818 | 0.85 | TDP1 (0.40) | TDP1KDM4ETSHR | |
| SCHEMBL4440314 | 0.85 | LMNA (0.40) | USP2TDP1LMNAALDH1A1KDM4E | |
| SCHEMBL632454 | 0.82 | USP2 (0.42) | USP2TDP1LMNAALDH1A1KDM4E | |
| SCHEMBL3902429 | 0.81 | TDP1 (0.38) | USP2TDP1LMNAALDH1A1KDM4E | |
| SCHEMBL3899149 | 0.81 | TDP1 (0.38) | USP2TDP1LMNAALDH1A1KDM4E | |
| SCHEMBL737250 | 0.81 | TDP1 (0.38) | USP2TDP1LMNAALDH1A1TSHR | |
| SCHEMBL12091542 | 0.79 | TSHR (0.39) | TDP1LMNATSHR | |
| SCHEMBL9219277 | 0.79 | THRB (0.46) | USP2TDP1LMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0066107-B1 | 2-HYDROXY-3-METHYL-BRANCHED-ALKOXYPROPYL GLYCERYL ETHER AND COSMETIC COMPOSITION CONTAINING SAME | Kao Corporation (JP) | 1985-08-14 | — | — | EP | claimed |
| US-11773266-B2 | Polymer, molded body, foam, resin composition, and production method for polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-03 | — | — | US | disclosed |
| US-20230129965-A1 | HYDROPHILIC AND OLEOPHOBIC POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-04-27 | — | — | US | disclosed |
| WO-2019142760-A1 | HYALURONIDASE ACTIVITY INHIBITOR | 株式会社ADEKA | 2019-07-25 | — | — | WO | disclosed |
| CN-108367517-A | Method for producing the haptic lens with lubricated surface | 诺华股份有限公司 | 2018-08-03 | — | — | CN | disclosed |
| US-20180030175-A1 | POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-01 | — | — | US | disclosed |
| US-8829229-B2 | Polyol ethers and process for making them | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-09 | — | — | US | disclosed |
| US-8829229-B2 | Polyol ethers and process for making them | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-09 | — | — | US | disclosed |
| EP-2318346-B1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-11-20 | — | — | EP | disclosed |
| US-8329818-B2 | Modified ethylene-vinyl alcohol copolymer and method for the production thereof | KURARAY CO., LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| WO-2010027663-A1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| US-20100048940-A1 | reductive etherification of a polyol with an aldehyde or ketone using a hydrogenation catalyt; resulting compounds have use as solvents, surfactants, degreasers, wetting agents, emulsifying agents, lubricants, and intermediates for surfactants; polyols can be from renewable raw materials | DOW GLOBAL TECHNOLOGIES LLC | 2010-02-25 | — | — | US | disclosed |
| WO-2009115273-A1 | NEW OXYGENATED COMPONENTS FOR FUELS AND PREPARATION THEREOF | ENI S.P.A. (IT) | 2009-09-24 | — | — | WO | disclosed |
| US-7534829-B2 | Resin composition and multi-layer structures | KURARAY CO., LTD. (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7365213-B2 | Organosilicon compound, organosilicon resin having diol, and processes for producing these | TOAGOSEI CO., LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-6657089-B1 | Reacting cyclic acetal containing hydroxy group with hydrogen in presence of palladium catalyst supported on mesoporous alumninosilicate; hydrogenation, decyclization, catalysis | KAO CORPORATION (JP) | 2003-12-02 | — | — | US | disclosed |
| EP-1236511-A1 | PALLADIUM CATALYST AND PROCESS FOR PRODUCING ETHER | Kao Corporation (JP) | 2002-09-04 | — | — | EP | disclosed |
| EP-0624563-A1 | Glycerin derivatives and process for producing the same | KAO CORPORATION (JP) | 1994-11-17 | — | — | EP | disclosed |
| EP-0080529-A1 | 2-Cyano-substituted 1,3-dioxane and dioxolane derivatives | THE DOW CHEMICAL COMPANY (US) | 1983-06-08 | — | — | EP | disclosed |
| US-4365073-A | Derivatives of cyano-substituted ketones and aldehydes | THE DOW CHEMICAL COMPANY (US) | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048940-A1 | reductive etherification of a polyol with an aldehyde or ketone using a hydrogenation catalyt; resulting compounds have use as solvents, surfactants, degreasers, wetting agents, emulsifying agents, lubricants, and intermediates for surfactants; polyols can be from renewable raw materials | RNF114, USP14, USP13 | USP2 70/4885TDP1 1846/4885LMNA 3728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.